Narayana Hrudayalaya Ltd. · NSE:NH
Narayana Hrudayalaya — Q2 FY25 Earnings Presentation
20 slides from Narayana Hrudayalaya's earnings presentation, Oct 31, 2024
Slide 1: Submission letter to BSE and NSE
Date of submission: October 31, 2024 To, To, The Secretary The Secretary Listing Department Listing Department BSE Limited National Stock Exchange of India Department of Corporate Services Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai – 400 001 Mumbai –
Slide 2: Earnings Update Q2 FY25
Earnings Update Q2 FY25 August 02, 2023
Slide 3: Index
Topic Slide No. Our Footprint 03 Narayana Health at a Glance 04 Q2 FY25 Highlights 05 Index Capex 13 NH Integrated Care and Insurance 14 Digital Transformation Initiatives 15 Narayana Health ESG Vision – “Health For All” 16 Shareholding Pattern 17 2
Slide 4: Our Footprint
Our Footprint As on 1st October 2024 South Hospitals - 6 | Heart Centres - 2 | Clinics - 12 Kakriyal, Jammu Operational beds - 2,006 (Hospitals) - 128 (Heart Centres) Delhi NCR East Hospitals - 7 | Clinics - 4| Dialysis Centre - 1 Jaipur Operational beds - 1,994 Guwahati Ahmedabad Jamshedpur Raipur
Slide 5: Narayana Health – At Glance
Narayana Health – At Glance 6,260 Facility Details No. of Facilities Operational Beds Capacity Beds Owned / Operated Hospitals(1) 19 5,551 5.5 Mns(2) Average Effective Capital Cost per Operational Bed Heart Centres 2 128 Clinics and Dialysis Centre 18 0 Total 19,760 Clinical : 12,040 Non-clinical :
Slide 6: Key Highlights – Operational & Financial Performance (Q2 FY25)
Key Highlights – Operational & Financial Performance (Q2 FY25) • Narayana Institute of Cardiac Sciences (NICS), Bengaluru has performed 113 Robotic Cardiac Surgeries in the quarter. • Rabindranath Tagore International Institute of Cardiac Science (RTIICS), Kolkata has performed Embolization of High
Slide 7: India Operations – Revenue (Q2 FY25)
India Operations – Revenue (Q2 FY25) Total (INR Mns)* Domestic Revenue (INR Mns) 15004 12004 10816 11677 9533 9958 10527 10848 10004 8.6% QoQ 10004 7.6% QoQ 8004 6004 5004 4004 2004 4 4 Q2 FY24 Q1 FY25 Q2 FY25 Q2 FY24 Q1 FY25 Q2 FY25 10.9% YoY 13.5% YoY International Revenue (INR Mns) Integrated Car
Slide 8: India Operations – Revenue Mix (Q2 FY25)
India Operations – Revenue Mix (Q2 FY25) Business Mix(7) Specialty-Profile(4,7) Payor-Profile(4,7) 7% 17% 27% 32% 4% 20% 45% 8% 1% 70% 1% 10% 13% 15% 29% Owned Hospitals (1) Cardiac Sciences Medicine and GI sciences Domestic Walk-in patients Operated Hospitals (2) Oncology Renal Sciences Insured Pat
Slide 9: Operational Review – India (Q2 FY25)
Operational Review – India (Q2 FY25) Average Revenue Per Patient (IP & OP) (1,2) ALOS INR ‘000 135.1 Days 130.0 4.5 118.1 4.4 4.4 4.3 4.3 OP 4.3 IP 4.2 4.1 4.4 4.3 4.1 4 Q2 FY24 Q1 FY25 Q2 FY25 Q2 FY24 Q1 FY25 Q2 FY25 Patient Footfalls (IP & OP)(1,3) 110 ICU Occupied Bed Days 685 710 ‘000 650 ‘000 1
Slide 10: Cluster Split – India (Q2 FY25)
Cluster Split – India (Q2 FY25) This considers owned/operated hospitals in India (excl. Jammu (1)) Southern Eastern Western Bangalore Kolkata Northern Peripheral Peripheral Regions • NICS • Mysore • RTIICS • Jamshedpur • Mumbai • Gurugram • MSMC • Shimoga • Barasat • Guwahati • Ahmedabad • New Delhi
Slide 11: Profitability Snapshot – India Hospitals (Q2 FY25)
Profitability Snapshot – India Hospitals (Q2 FY25) Excludes NHIC, NHIL, ATHMA & MEDHA (2) EBITDA and EBITDA Margin (1) Cost Structure INR ‘Mns % of Operating Revenues Chart Title Share Rental / Revenue (7) 2,600 21.0% 21.0% 2.3% 1.8% 1.8% 2,400 100% 20.0% 20.3% 90% 11.5% 12.2% 11.6% 2,200 19.4% 80%
Slide 12: Operational Review – Cayman Islands
Operational Review – Cayman Islands Average Revenue Per Patient (IP & OP) Operating Revenues US$ ‘00040.0 34.1 US$ Mns 31.9 31.9 34.0 31.5 32.0 30.0 OP 32.0 20.0 30.0 29.0 IP 28.0 10.0 1.3 1.5 1.4 26.0 0.0 24.0 Q2FY24 Q1 FY25 Q2 FY25 Q2 FY24 Q1 FY25 Q2 FY25 Discharges Out-Patients 600 584 10,000 9,6
Slide 13: Consolidated Financial Performance
Consolidated Financial Performance Figures in INR Mns, unless stated otherwise Profit and Loss Statement(1) Key Balance Sheet Items(1) Particulars (INR Mns) Q2 FY25 H1 FY25 Particulars 30th Sept 2024 Total Operating Revenue 14,000 27,410 Shareholder Equity 32,073 Consumption 3,002 5,884 Doctors Expe
Slide 14: Capex Strategy
Capex Strategy INR Mns FY24 FY25 Block A interiors, 9,100 NICU, PICU, Single Facility Transformation Rooms, Medical in Existing Hospitals Equipment 2,214 Infrastructure Medical Equipment Reconfiguration, 1,350 Replacement and New Replacement Medical 2,181 Purchases Equipment 866 3,237 1,629 149 Lina
Slide 15: NH Integrated Care and Insurance: Snapshot
NH Integrated Care and Insurance: Snapshot Program running since September 2022 at select Bengaluru locations 9* 88,227* ₹98.91 Mn.* ₹1.23 Mn.** Q2 FY25 Q2 FY25 YTD Q2 FY25 As on 30th September 2024 Points of Presence Patient Transactions Revenue - Integrated Care GWP - Insurance Integrated Care now
Slide 16: Digital Transformation Initiatives
Digital Transformation Initiatives Impact | Mobile Apps Launch | New Products Initiatives | Business GTM | Athma • 50% in-patient documents • Outpatient Access-control pilot • 10% reduction in lab and radiology • 750 Beds across 4 facilities added reduced with mobile app launched reporting turnaroun
Slide 17: NH ESG Vision – “Health For All”
Actuals FY 24~25 - 6M (Target FY 24~25 – 6M) NH ESG Vision – “Health For All” A Healthy Planet By being conscious about impact on the environment, prioritizing consumption efficiency and resource optimization 35% Carbon Neutral 100% Optimized 50% less Renewable Energy By 2040 Waste-water Waste manag
Slide 18: Shareholding Pattern
Shareholding Pattern As on 30th Sept 2024(1) ESOP Trust DIIs 0.6% Total Number of Shares 9.5% 204,360,804 FIIs 9.7% Key DIIs Key FIIs Axis Asset Management Simcah Partners LP SBI Life Insurance Co. Ltd. Franklin Templeton Investment Funds ICICI Prudential Life Insurance Co. Ltd. Government Pension F
Slide 19: Disclaimer and Contact Details
Disclaimer and Contact Details No representation or warranty, express or implied is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of such information or opinions contained herein. The information contained in this presentation is only current as
Slide 20: Take Care
i. a Take Care